EPO and bipolar disorder: In another double-blind, randomized, placebo-controlled, phase II trial on bipolar disorder, EPO was shown to improve processing speed for learning, attention (p < 0.05), executive functions (p < 0.05), recognition of happy faces (p < 0.05), and sustained attention (p < 0.05) (107).